Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Steven I, Blum"'
Autor:
Nisha A. Mohindra, John Devin Peipert, Steven I. Blum, James W. Shaw, John R. Penrod, David Cella
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12765-12776 (2023)
Abstract Background Therapeutic advances in lung cancer have turned attention toward patient‐reported outcome measures (PROMs) as important clinical outcomes. The Functional Assessment of Cancer Therapy‐Lung (FACT‐L) is a common endpoint in lun
Externí odkaz:
https://doaj.org/article/d131fb5d0d4a4802b80e1148c6230625
Autor:
Susan D. Mathias, Steven I. Blum, Vanja Sikirica, Kirsten L. Johansen, Hilary H. Colwell, Tony Okoro
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-10 (2020)
Abstract Background Anemia is a frequent complication of chronic kidney disease (CKD) that negatively affects patients’ health-related quality of life. Methods We conducted qualitative concept elicitation (CE) and cognitive debriefing (CD) intervie
Externí odkaz:
https://doaj.org/article/69988b7109314a80b3ca4f61a7c7433f
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-11 (2019)
Abstract Purpose To conduct qualitative interviews to evaluate and refine the Itch Diary (ID) and weekly version of the PBC-40 in patients with itching associated with primary biliary cholangitis (PBC). Methods Twenty adults with self-reported PBC di
Externí odkaz:
https://doaj.org/article/a10508c01d354872b5114b144163df8e
Autor:
Martin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Zurawski, Juliana Menezes, Eduardo Richardet, Jaafar Bennouna, Enriqueta Felip, Oscar Juan-Vidal, Aurelia Alexandru, Ying Cheng, Hiroshi Sakai, Luis Paz-Ares, Shun Lu, Thomas John, Xiaowu Sun, Aniela Moisei, Fiona Taylor, Rachael Lawrance, Xiaoqing Zhang, Judi Sylvester, Yong Yuan, Steven I. Blum, John R. Penrod, David P. Carbone
Publikováno v:
European Journal of Cancer. 183:174-187
Autor:
Julie R. Brahmer, Jong-Seok Lee, Tudor-Eliade Ciuleanu, Reyes Bernabe Caro, Makoto Nishio, Laszlo Urban, Clarisse Audigier-Valette, Lorena Lupinacci, Randeep Sangha, Adam Pluzanski, Jacobus Burgers, Mauricio Mahave, Samreen Ahmed, Adam J. Schoenfeld, Luis G. Paz-Ares, Martin Reck, Hossein Borghaei, Kenneth J. O'Byrne, Ravi G. Gupta, Judith Bushong, Li Li, Steven I. Blum, Laura J. Eccles, Suresh S. Ramalingam
Publikováno v:
Journal of Clinical Oncology. 41:1200-1212
PURPOSE We present 5-year results from CheckMate 227 Part 1, in which nivolumab plus ipilimumab improved overall survival (OS) versus chemotherapy in patients with metastatic non–small-cell lung cancer, regardless of tumor programmed death ligand 1
Autor:
Nisha A. Mohindra, John Devin Peipert, Steven I. Blum, James W. Shaw, John R. Penrod, David Cella
Publikováno v:
Cancer Medicine.
Autor:
Bradley McGregor, Daniel M. Geynisman, Mauricio Burotto, Cristina Suárez, Maria T. Bourlon, Pedro C. Barata, Shuchi Gulati, Stephen Huo, Flavia Ejzykowicz, Steven I. Blum, Viviana Del Tejo, Melissa Hamilton, Jessica R. May, Ella X. Du, Aozhou Wu, Pavol Kral, Cristina Ivanescu, Andi Chin, Keith A. Betts, Chung-Han Lee, Toni K. Choueiri, David Cella, Camillo Porta
Publikováno v:
European Urology Oncology.
Autor:
Sonya, Eremenco, Wen-Hung, Chen, Steven I, Blum, Elizabeth Nicole, Bush, Donald M, Bushnell, Kendra, DeBusk, Adam, Gater, Linda, Nelsen, Stephen Joel, Coons
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 31(12)
Score reproducibility is an important measurement property of fit-for-purpose patient-reported outcome (PRO) measures. It is commonly assessed via test-retest reliability, and best evaluated with a stable participant sample, which can be challenging
Autor:
David Cella, Robert J Motzer, Cristina Suarez, Steven I Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel F Wallace, Burcin Simsek, Joshua Zhang, Cristina Ivanescu, Andrea B Apolo, Toni K Choueiri
Publikováno v:
Lancet Oncol
In the CheckMate 9ER trial, patients with advanced renal cell carcinoma who received first-line nivolumab plus cabozantinib had significantly better progression-free survival compared with those given sunitinib. In this study, we aimed to describe th
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-11 (2019)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes
Purpose To conduct qualitative interviews to evaluate and refine the Itch Diary (ID) and weekly version of the PBC-40 in patients with itching associated with primary biliary cholangitis (PBC). Methods Twenty adults with self-reported PBC diagnoses a